SCHEMBL712303

SCHEMBL712303

[CH2]C([CH2])=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL316938 0.77
SCHEMBL2414 0.77
SCHEMBL3676073 0.77
SCHEMBL44936 0.72
SCHEMBL20696084 0.72
SCHEMBL23309783 0.72
SCHEMBL19469325 0.72
SCHEMBL20258259 0.72
SCHEMBL20957485 0.72
SCHEMBL1726770 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 215 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11261401-B2 Synthesis of 1,3-olein-2-palmitin (OPO) SOCIETE DES PRODUITS NESTLE S.A. (CH) 2022-03-01 US claimed
US-20200190430-A1 SYNTHESIS OF 1,3-OLEIN-2-PALMITIN (OPO) NESTEC S.A. (CH) 2020-06-18 US claimed
CN-111032877-A Synthesis of 1, 3-dioleoyl-2-palmitoyl triglyceride (OPO) 雀巢产品有限公司 2020-04-17 CN claimed
EP-2714769-B1 PROCESS FOR THE POLYMERIZATION OF CYCLIC CARBONATES TOTAL RES & TECHNOLOGY FELUY (BE) 2017-04-19 EP claimed
EP-2307478-B1 CATALYTIC PROCESS FOR POLYMERISING CYCLIC CARBONATES ISSUED FROM RENEWABLE RESOURCES. TOTAL RES & TECHNOLOGY FELUY (BE) 2013-11-20 EP claimed
EP-2247643-B1 MONOMERS ISSUED FROM RENEWABLE RESOURCES AND PROCESS FOR POLYMERISING THEM TOTAL PETROCHEMICALS RES FELUY (BE) 2012-05-09 EP claimed
US-6166212-A Process for the synthesis of N-(hydroxyalkoxy) substituted hindered amine stabilizers CIBA SPECIALTY CHEMICALS CORPORATION (US) 2000-12-26 US claimed
US-5138054-A Colorfastness, photostability; red dye BAYER AKTIENGESELLSCHAFT (DE) 1992-08-11 US claimed
EP-0010361-B1 BIS-IMIDAZOLES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SMITHKLINE BECKMAN CORPORATION (US) 1983-04-27 EP claimed
EP-0010361-A1 Bis-imidazoles, their preparation and pharmaceutical compositions containing them SMITHKLINE BECKMAN CORPORATION (US) 1980-04-30 EP claimed
US-11975073-B2 Lipid prodrugs of neurosteroids PURETECH LYT, INC. (US) 2024-05-07 US disclosed
US-20230338552-A1 LIPID PRODRUGS OF NEUROSTEROIDS PURETECH LYT, INC. (US) 2023-10-26 US disclosed
CN-116496334-A Antiviral inhibitor and application thereof in pharmacy 上海和誉生物医药科技有限公司 2023-07-28 CN disclosed
US-11649215-B2 Compositions and methods for the treatment of oral infectious diseases CELLIX BIO PRIVATE LIMITED (IN) 2023-05-16 US disclosed
US-20220395513-A1 LIPID PRODRUGS OF NEUROSTEROIDS PURETECH LYT, INC. (US) 2022-12-15 US disclosed
EP-0001125-B1 CEPHALOSPORIN DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-11-11 EP disclosed
US-4234014-A Bowl for compressed air or gas filter or lubricator IMI NORGREN LIMITED (GB) 1980-11-18 US disclosed
EP-0010361-A1 Bis-imidazoles, their preparation and pharmaceutical compositions containing them SMITHKLINE BECKMAN CORPORATION (US) 1980-04-30 EP disclosed
EP-0010361-A1 Bis-imidazoles, their preparation and pharmaceutical compositions containing them SMITHKLINE BECKMAN CORPORATION (US) 1980-04-30 EP disclosed
EP-0001125-A2 Cephalosporin derivatives, processes for their preparation and pharmaceutical compositions containing them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1979-03-21 EP disclosed